<DOC>
	<DOC>NCT02007603</DOC>
	<brief_summary>The study will be conducted to investigate the pharmacokinetics of ampicillin / sulbactam and amoxicillin/clavulanic acid during intermittent haemodialysis.</brief_summary>
	<brief_title>Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients</brief_title>
	<detailed_description />
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Age &gt;18 years Suspected or proven bacterial infection requiring parenteral antibiotic therapy. Renal replacement therapy (HD) Known hypersensitivity to ampicillin / sulbactam, amoxicillin / clavulanic acid or other betalactames, or severe hypersensitivity (anaphylactic reaction) to betalactam antibacterial agents. An expected survival of less than two days. Known pregnancy Coadministration of one of the following drugs: probenecid which cannot be discontinued for the duration of the study Ampicillin / sulbactam respectively amoxicillin / clavulanic acid as monotherapy for resistant species or fungal infections. Other reasons opposing the study participation on the discretion of the investigators.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>chronic hemodialysis</keyword>
	<keyword>ampicillin</keyword>
	<keyword>sulbactam</keyword>
	<keyword>amoxicillin</keyword>
	<keyword>clavulanic acid</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>